Qiagen NV reported $533.54M in Sales Revenues for its fiscal quarter ending in June of 2025.


Sales Change Date
Alaunos Therapeutics USD 0 4K Sep/2024
argenx SE USD 842.5M 132.26M Jun/2025
Avita Medical AUD 18.41M 7.89M Dec/2024
Dianthus Therapeutics USD 193K 1.13M Jun/2025
Ionis Pharmaceuticals USD 452M 320M Jun/2025
IQVIA Holdings USD 4.02B 190M Jun/2025
Moderna USD 142M 34M Jun/2025
Organon & Co 1.59B 80M Jun/2025
Qiagen NV USD 533.54M 108.24M Jun/2025
Revvity USD 720M 55M Jun/2025
Tectonic Therapeutic 0 0 Dec/2024
Viatris USD 3.57B 320M Jun/2025
Xeris Pharmaceuticals USD 71.54M 11.44M Jun/2025